<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Intermediate- and long-acting medications for children with attention deficit hyperactivity disorder</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Intermediate- and long-acting medications for children with attention deficit hyperactivity disorder</h1>
<div class="graphic"><div class="figure"><div class="ttl">Intermediate- and long-acting medications for children with attention deficit hyperactivity disorder</div><div class="cntnt"><table cellspacing="0"><colgroup span="6" width="16%"></colgroup> <tbody> <tr> <td class="subtitle1">Medication</td> <td class="subtitle1">United States trade name<br/> (generic availability)</td> <td class="subtitle1">Description of release and duration of action</td> <td class="subtitle1">Initial dose<sup>*</sup></td> <td class="subtitle1">Dose advancement</td> <td class="subtitle1">Maximum dose<br/> (per day)</td> </tr> <tr> <td class="subtitle2_left" colspan="6">Methylphenidate</td> </tr> <tr> <td class="indent1">Methylphenidate ER <ul class="decimal_heading"> <li>10, 20 mg tablets</li> </ul> </td> <td> <ul> <li>Metadate ER (generic available)</li> </ul> </td> <td> <ul> <li>Delayed onset with continuous release over 3 to 8 hours. May require twice daily dosing and/or use with immediate-release methylphenidate.</li> <li>Tablet must be swallowed whole.</li> </ul> </td> <td> <ul> <li>10 mg</li> </ul> </td> <td> <ul> <li>Increments of 10 mg per day every 3 to 7 days</li> </ul> </td> <td> <ul> <li>≤50 kg: 60 mg</li> <li>&gt;50 kg: 100 mg<sup>¶</sup></li> </ul> </td> </tr> <tr> <td class="indent1">Methylphenidate ER chewable tablets <ul class="decimal_heading"> <li>20 mg (scored), 30 mg (scored), 40 mg (not scored)</li> </ul> </td> <td> <ul> <li>Quillichew ER</li> </ul> </td> <td> <ul> <li>Continuous release over 6 to 8 hours with duration of action up to 13 hours.</li> </ul> </td> <td> <ul> <li>20 mg</li> </ul> </td> <td> <ul> <li>Increments of 10 mg, 15 mg, or 20 mg per day every 7 days</li> </ul> </td> <td> <ul> <li>60 mg</li> </ul> </td> </tr> <tr> <td class="indent1">Methylphenidate XR-ODT <ul class="decimal_heading"> <li>8.6, 17.3, 25.9 mg tablets as methylphenidate base (equivalent to 10, 20, 30 mg of methylphenidate hydrochloride)<sup>Δ</sup></li> </ul> </td> <td> <ul> <li>Cotempla XR-ODT</li> </ul> </td> <td> <ul> <li>25% immediate-release and 75% extended-release for duration of action up to 12 hours.</li> <li>Whole tablet must be dissolved on tongue; should be taken consistently either with or without food.<sup>◊</sup></li> </ul> </td> <td> <ul> <li>17.3 mg</li> </ul> </td> <td> <ul> <li>Increments of 8.6 to 17.3 mg per day every 7 days</li> </ul> </td> <td> <ul> <li>51.8 mg</li> </ul> </td> </tr> <tr> <td class="indent1">Methylphenidate ER (OROS) <ul class="decimal_heading"> <li>18, 27, 36, 54, 63, 72 mg tablets</li> </ul> </td> <td> <ul> <li>Concerta, Relexxii (generics for Concerta with limited availability)</li> </ul> </td> <td> <ul> <li>20% immediate-release and 80% continuous-release over 10 to 12 hours by osmotic delivery.</li> <li>Tablet must be swallowed whole.</li> </ul> </td> <td> <ul> <li>18 mg</li> </ul> </td> <td> <ul> <li>Increments of 9 to 18 mg per dose every 3 to 7 days</li> </ul> </td> <td> <ul> <li>&lt;13 years: 54 mg</li> <li>≥13 years: 72 mg</li> </ul> </td> </tr> <tr> <td class="indent1">Methylphenidate LA <ul class="decimal_heading"> <li>10, 20, 30, 40 mg capsules</li> </ul> </td> <td> <ul> <li>Ritalin LA (generic available except 10 mg)</li> </ul> </td> <td> <ul> <li>50% immediate-release and 50% delayed-release over 8 to 12 hours (bimodal).</li> <li>Capsule may be swallowed whole or opened and contents sprinkled over a spoonful of cold applesauce and swallowed immediately; capsule or contents should not be crushed or chewed.</li> </ul> </td> <td> <ul> <li>10 or 20 mg</li> </ul> </td> <td> <ul> <li>Increments of 10 or 20 mg per dose every 3 to 7 days</li> </ul> </td> <td> <ul> <li>≤50 kg: 60 mg</li> <li>&gt;50 kg: 100 mg<sup>¶</sup></li> </ul> </td> </tr> <tr> <td class="indent1">Methylphenidate CD <ul class="decimal_heading"> <li>10, 20, 30, 40, 50, 60 mg capsules</li> </ul> </td> <td> <ul> <li>Generic available</li> </ul> </td> <td> <ul> <li>30% immediate-release and 70% delayed-release over 8 to 12 hours (bimodal).</li> <li>Capsule may be swallowed whole or opened and contents sprinkled over a spoonful of cold applesauce and swallowed immediately; capsule or contents should not be crushed or chewed.</li> </ul> </td> <td> <ul> <li>20 mg</li> </ul> </td> <td> <ul> <li>Increments of 10 mg per dose every 3 to 7 days</li> </ul> </td> <td> <ul> <li>≤50 kg: 60 mg</li> <li>&gt;50 kg: 100 mg<sup>¶</sup></li> </ul> </td> </tr> <tr> <td class="indent1">Methylphenidate XR <ul class="decimal_heading"> <li>10, 15, 20, 30, 40, 50, 60 mg capsules</li> </ul> </td> <td> <ul> <li>Aptensio XR (generic available)</li> </ul> </td> <td> <ul> <li>40% immediate release and 60% controlled release for duration of action of 12 hours.</li> <li>Capsule may be swallowed whole or opened and contents sprinkled over a spoonful of cold applesauce and swallowed immediately; capsule or contents should not be crushed or chewed.</li> </ul> </td> <td> <ul> <li>10 mg</li> </ul> </td> <td> <ul> <li>Increments of 10 mg every 7 days</li> </ul> </td> <td> <ul> <li>60 mg</li> </ul> </td> </tr> <tr> <td class="indent1">Methylphenidate XR oral suspension <ul class="decimal_heading"> <li>5 mg/mL</li> </ul> </td> <td> <ul> <li>Quillivant XR</li> </ul> </td> <td> <ul> <li>20% immediate-release and 80% extended-release for duration of action up to 12 hours.</li> </ul> </td> <td> <ul> <li>20 mg</li> </ul> </td> <td> <ul> <li>Increments of 10 mg every 7 days</li> </ul> </td> <td> <ul> <li>60 mg</li> </ul> </td> </tr> <tr> <td class="indent1">Methylphenidate extended release capsules <ul class="decimal_heading"> <li>20, 40, 60, 80, 100 mg capsules</li> </ul> </td> <td> <ul> <li>Jornay PM</li> </ul> </td> <td> <ul> <li>&lt;5% of total drug is available within the first 10 hours after administration.</li> <li>Peak concentration occurs 14 hours after dose with gradual decline thereafter.</li> <li>Capsules may be swallowed whole or opened and the contents sprinkled over a spoonful of cold applesauce; capsule or contents should not be crushed or chewed.</li> </ul> </td> <td> <ul> <li>20 mg per day in the evening (adjust timing to optimize tolerability and efficacy)</li> </ul> </td> <td> <ul> <li>Increments of 20 mg per day every 7 days</li> </ul> </td> <td> <ul> <li>100 mg</li> </ul> </td> </tr> <tr> <td class="indent1">Methylphenidate patch<sup>§</sup> <ul class="decimal_heading"> <li>10, 15, 20, 30 mg patch</li> </ul> </td> <td> <ul> <li>Daytrana</li> </ul> </td> <td> <ul> <li>Onset 2 hours after application of patch and continuous release over 9 to 12 hours.</li> </ul> </td> <td> <ul> <li>10 mg<sup>§</sup></li> </ul> </td> <td> <ul> <li>Increments of 5 mg per dose every 3 to 7 days</li> </ul> </td> <td> <ul> <li>30 mg</li> </ul> </td> </tr> <tr> <td class="subtitle2_left" colspan="6">Dexmethylphenidate</td> </tr> <tr> <td class="indent1">Dexmethylphenidate XR <ul class="decimal_heading"> <li>5, 10, 15, 20, 25, 30, 35, 40 mg capsules</li> </ul> </td> <td> <ul> <li>Focalin XR (generic available)</li> </ul> </td> <td> <ul> <li>50% immediate-release and 50% delayed-release over 10 to 12 hours (bimodal).</li> <li>Capsule may be swallowed whole or opened and contents sprinkled over a spoonful of cold applesauce and swallowed immediately; capsule or contents should not be crushed or chewed.</li> </ul> </td> <td> <ul> <li>5 mg</li> </ul> </td> <td> <ul> <li>Increments of 5 mg per dose every 3 to 7 days</li> </ul> </td> <td> <ul> <li>40 mg</li> </ul> </td> </tr> <tr> <td class="indent1" rowspan="2">Serdexmethylphenidate-dexmethylphenidate <ul class="decimal_heading"> <li>26.1/5.2, 39.2/7.8, 52.3/10.4 mg capsules</li> </ul> </td> <td rowspan="2"> <ul> <li>Azstarys</li> </ul> </td> <td rowspan="2"> <ul> <li>70% serdexmethylphenidate (dexmethylphenidate prodrug) and 30% dexmethylphenidate (immediate release).</li> <li>Peak dexmethylphenidate concentration occurs approximately 2 hours after the dose (onset of action within 1 hour), with gradual decline thereafter for duration of action of up to 13 hours.</li> <li>Capsule may be swallowed whole or opened and contents sprinkled over 2 tablespoons of applesauce or into 50 mL of water and consumed within 10 minutes of mixing.</li> </ul> </td> <td>Age 6 to 12 years: <ul class="decimal_heading"> <li>39.2/7.8 mg</li> </ul> </td> <td> <ul> <li>Increase or decrease by 13.1/2.6 mg after one week</li> </ul> </td> <td rowspan="2"> <ul> <li>52.3/10.4 mg</li> </ul> </td> </tr> <tr> <td>Age ≥13 years: <ul class="decimal_heading"> <li>39.2/7.8 mg</li> </ul> </td> <td> <ul> <li>Increase to 52.3/10.4 after 1 week</li> </ul> </td> </tr> <tr> <td class="subtitle2_left" colspan="6">Amphetamines</td> </tr> <tr> <td class="indent1">Dextroamphetamine-amphetamine ER <ul class="decimal_heading"> <li>5, 10, 15, 20, 25, 30 mg capsules<sup>¥</sup></li> </ul> </td> <td> <ul> <li>Adderall XR (generic available)</li> </ul> </td> <td> <ul> <li>Combination of immediate- and continuous-release over 10 to 12 hours.</li> </ul> </td> <td> <ul> <li>5 mg</li> </ul> </td> <td> <ul> <li>Increments of 5 mg per dose every 3 to 7 days</li> </ul> </td> <td> <ul> <li>≤50 kg: 40 mg</li> <li>&gt;50 kg: 60 mg<sup>‡</sup></li> </ul> </td> </tr> <tr> <td class="indent1">Dextroamphetamine-amphetamine ER <ul class="decimal_heading"> <li>12.5, 25, 37.5, 50 mg capsules<sup>¥†</sup></li> </ul> </td> <td> <ul> <li>Mydayis</li> </ul> </td> <td> <ul> <li>Combination of immediate- and two different delayed-release beads for duration up to 16 hours.</li> <li>Capsule may be swallowed whole or sprinkled over a spoonful of cold applesauce and swallowed immediately; capsule or contents should not be crushed or chewed.</li> </ul> </td> <td> <ul> <li>12.5 mg</li> </ul> </td> <td> <ul> <li>Increments of 12.5 mg every 7 days</li> </ul> </td> <td> <ul> <li>13 through 17 years: 25 mg</li> <li>≥18 years: 50 mg</li> </ul> </td> </tr> <tr> <td class="indent1">Amphetamine ER <ul class="decimal_heading"> <li>Oral suspension 2.5 mg amphetamine as base per mL<sup>¥</sup></li> <li>5, 10, 15, and 20 mg tablets</li> </ul> </td> <td> <ul> <li>Dyanavel XR</li> </ul> </td> <td> <ul> <li>Combination of immediate- and extended-release for duration of action up to 13 hours.</li> <li>Tablets may be chewed or swallowed whole.</li> </ul> </td> <td> <ul> <li>2.5 or 5 mg</li> </ul> </td> <td> <ul> <li>Increments of 2.5 to 10 mg per day every 4 to 7 days</li> </ul> </td> <td> <ul> <li>20 mg</li> </ul> </td> </tr> <tr> <td class="indent1">Amphetamine ER <ul class="decimal_heading"> <li>ODT 3.1, 6.3, 9.4, 12.5, 15.7, 18.8 mg as base<sup>¥</sup></li> </ul> </td> <td> <ul> <li>Adzenys XR-ODT</li> </ul> </td> <td> <ul> <li>Combination of 50% immediate- and 50% extended-release; levels are comparable to dextroamphetamine-amphetamine ER capsules when equivalent doses are used.<sup>¥</sup></li> </ul> </td> <td> <ul> <li>6.3 mg</li> </ul> </td> <td> <ul> <li>Increments of 3.1 or 6.3 mg per day every 7 days</li> </ul> </td> <td> <ul> <li>6 to 12 years: 18.8 mg</li> <li>≥13 years: 12.5 mg</li> </ul> </td> </tr> <tr> <td class="indent1">Dextroamphetamine SR <ul class="decimal_heading"> <li>5, 10, 15 mg capsules</li> </ul> </td> <td> <ul> <li>Generic extended release available (Dexedrine Spansule brand is no longer available)</li> </ul> </td> <td> <ul> <li>Combination of immediate- and continuous-release over 8 to 12 hours.</li> <li>May require dividing dose twice daily.</li> </ul> </td> <td> <ul> <li>5 mg</li> </ul> </td> <td> <ul> <li>Increments of 5 mg per day every 3 to 7 days</li> </ul> </td> <td> <ul> <li>≤50 kg: 40 mg</li> <li>&gt;50 kg: 60 mg<sup>‡</sup></li> </ul> </td> </tr> <tr> <td class="indent1">Dextroamphetamine patch<sup>§</sup> <ul class="decimal_heading"> <li>4.5, 9, 13.5, 18 mg per 9 hour patches</li> </ul> </td> <td> <ul> <li>Xelstrym</li> </ul> </td> <td> <ul> <li>Strength is amount of dextroamphetamine released from patch over 9 hours.</li> <li>Onset 2 hours after application of patch; continuous release from application site over 9 to 12 hours.</li> </ul> </td> <td> <ul> <li>4.5 mg<sup>§</sup></li> </ul> </td> <td> <ul> <li>Increments of 4.5 mg per day every 7 days</li> </ul> </td> <td> <ul> <li>18 mg</li> </ul> </td> </tr> <tr> <td class="indent1">Lisdexamfetamine <ul class="decimal_heading"> <li>10, 20, 30, 40, 50, 60, 70 mg capsules</li> <li>10, 20, 30, 40, 50, 60 mg chewable tablets</li> </ul> </td> <td> <ul> <li>Vyvanse</li> </ul> </td> <td> <ul> <li>Prodrug converted to dextroamphetamine in bloodstream with an effect over approximately 10 hours.</li> <li>Capsule may be opened and dissolved in water or juice for immediate use.</li> <li>Chewable tablets must be chewed completely before swallowing.</li> </ul> </td> <td> <ul> <li>20 mg</li> </ul> </td> <td> <ul> <li>Increments of 10 or 20 mg per day every 3 to 7 days</li> </ul> </td> <td> <ul> <li>70 mg</li> </ul> </td> </tr> <tr> <td class="subtitle2_left" colspan="6">Nonstimulants</td> </tr> <tr> <td class="subtitle3_left" colspan="6">Selective norepinephrine reuptake inhibitors</td> </tr> <tr> <td class="indent2">Atomoxetine <ul class="decimal_heading"> <li>10, 18, 25, 40, 60, 80, 100 mg capsules</li> </ul> </td> <td> <ul> <li>Strattera (generic available)</li> </ul> </td> <td> <ul> <li>At least 10 to 12 hours.</li> </ul> </td> <td> <ul> <li>0.5 mg/kg per day for minimum of 3 days</li> </ul> </td> <td> <ul> <li>Increase to 1.2 mg/kg per day after a minimum of 3 days (maximum 100 mg per day)</li> </ul> </td> <td> <ul> <li>Lesser of 1.4 mg/kg or 100 mg</li> </ul> </td> </tr> <tr> <td class="indent2" rowspan="2">Viloxazine ER <ul class="decimal_heading"> <li>100, 150, 200 mg capsules</li> </ul> </td> <td rowspan="2"> <ul> <li>Qelbree</li> </ul> </td> <td rowspan="2"> <ul> <li>Lasts throughout the day.</li> <li>Capsule may be swallowed whole or opened and contents sprinkled over a teaspoonful of applesauce and swallowed immediately and without chewing; neither the capsule nor contents should be crushed or chewed.</li> </ul> </td> <td>Age 6 to 11: <ul class="decimal_heading"> <li>100 mg</li> </ul> </td> <td> <ul> <li>Increments of 100 mg weekly</li> </ul> </td> <td rowspan="2"> <ul> <li>400 mg</li> </ul> </td> </tr> <tr> <td>Age 12 to 17: <ul class="decimal_heading"> <li>200 mg</li> </ul> </td> <td> <ul> <li>Increments of 200 mg weekly</li> </ul> </td> </tr> <tr> <td class="subtitle3_left" colspan="6">Alpha-2 adrenergic agonists</td> </tr> <tr> <td class="indent2">Guanfacine ER<sup>**</sup> <ul class="decimal_heading"> <li>1, 2, 3, 4 mg tablets</li> </ul> </td> <td> <ul> <li>Intuniv (generic available)</li> </ul> </td> <td> <ul> <li>At least 10 to 12 hours.</li> </ul> </td> <td> <ul> <li>1 mg per day</li> </ul> </td> <td> <ul> <li>Increments of 1 mg per day at no less than weekly intervals</li> </ul> </td> <td> <ul> <li>≤12 years: 4 mg</li> <li>&gt;12 years: 7 mg<sup>¶¶</sup></li> </ul> </td> </tr> <tr> <td class="indent2">Clonidine ER<sup>**</sup> <ul class="decimal_heading"> <li>0.1 mg tablets</li> </ul> </td> <td> <ul> <li>Kapvay (generic available)</li> </ul> </td> <td> <ul> <li>At least 10 to 12 hours.</li> </ul> </td> <td> <ul> <li>0.1 mg at bedtime</li> </ul> </td> <td> <ul> <li>Increments of 0.1 mg per day every 7 days; doses &gt;0.1 mg per day are divided twice daily (either split equally or with higher dose administered at bedtime)</li> </ul> </td> <td> <ul> <li>0.4 mg</li> </ul> </td> </tr> </tbody></table></div><div class="graphic_footnotes"><p>CD: controlled dispense; 
        ER: extended release; 
        LA: long-acting; 
        ODT: orally disintegrating tablet; 
        OROS: osmotic controlled-release formulation; 
        SR: sustained release; 
        XR: extended release.</p>
<p>* Suggested doses for initiating treatment with long-acting stimulant medications for treatment of children aged ≥6 years.</p>
<p>¶ This maximum dose exceeds the US Food and Drug Administration (FDA)-approved maximum dose; careful monitoring for adverse effects is warranted.</p>
<p>Δ Cotempla XR-ODT strengths are expressed by the manufacturer as methylphenidate base. Most other methylphenidate product doses are expressed as methylphenidate hydrochloride salt. Cotempla XR-ODT dose needs to be converted to methylphenidate hydrochloride for comparison with other methylphenidate products.</p>
<p>◊ Although the prescribing information indicates that Cotempla XR-ODT should be taken consistently with or without food, we suggest that it be taken consistently with food – given the general stimulant effect of appetite suppression.</p>
<p>§ Patch is applied 2 hours before needed effect and worn for a total of 9 hours. Doses for the methylphenidate and dextroamphetamine patches are not equivalent to those for the oral preparations.</p>
<p>¥ Amphetamine ER oral suspension and ODT strengths reflect milligrams of amphetamine base, whereas dextroamphetamine-amphetamine ER capsule strengths reflect milligrams of dextroamphetamine-amphetamine salts. These cannot be substituted on an mg-per-mg basis. Refer to UpToDate content related to dose equivalents of stimulants for attention deficit hyperactivity disorder in children.</p>
<p>‡ Doses above 40 mg per day total are rarely necessary and warrant close monitoring.</p>
<p>† Mydayis is not approved by the FDA for children &lt;13 years.</p>
<p>** Immediate-release form cannot be substituted mg-for-mg for ER form due to pharmacokinetic differences. Discontinuation requires dose tapering to prevent rebound increase in blood pressure.</p>
    ¶¶ The typical maximum dose for this age group is 4 mg/day; a maximum dose of 7 mg/day may be used for adolescents &gt;12 years who weigh &gt;58.5 kg (120 pounds), but the 7 mg dose may be associated with somnolence.</div><div class="graphic_reference">Data from:
    <ol>
<li>Pliszka S, AACAP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2007; 46:894.</li>
<li>Drugs for ADHD. Med Lett Drugs Ther 2020; 62:9.</li>
<li>Wender EH. Managing stimulant medication for attention-deficit/hyperactivity disorder. Pediatr Rev 2001; 22:183.</li>
</ol>
<p class="extra_spacing_top">Prepared with additional data from the US Food and Drug Administration approved product information, available at <a href="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm" target="_blank">https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm</a> (accessed on March 29, 2022).</p></div><div id="graphicVersion">Graphic 77580 Version 37.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
